treatment

Angie Szumlinski
|
June 28, 2021
New Medication for Schizophrenia and Bipolar I

Angie Szumlinski
|
June 10, 2021
FDA Grants Accelerated Approval for Alzheimer’s Drug

Angie Szumlinski
|
April 16, 2021
FDA News Release – Multiple Sclerosis

Angie Szumlinski
|
March 9, 2021
FDA Curbs use of Convalescent Plasma
Stay informed with Angie’s expert perspective on current clinical challenges, industry trends, and real-world risk insights.
